Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Moehs Catalana SL
02 1Anonima Materie Sintetiche and Affini (AMSA) Spa
03 1Willow Birch Pharma, Inc.
04 1LETCO MEDICAL, LLC
05 1Medisca Inc.
06 1Professional Compounding Centers of America dba PCCA
07 1Spectrum Chemicals and Laboratory Products
08 1Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.
01 2AMANTADINE HYDROCHLORIDE
02 6Amantadine Hydrochloride
01 1China
02 1Italy
03 1Spain
04 4U.S.A
05 1United Kingdom
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0707
Start Marketing Date : 2009-09-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17373-1446
Start Marketing Date : 2014-10-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
NDC Package Code : 10695-014
Start Marketing Date : 2016-07-11
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2559
Start Marketing Date : 2012-02-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0411
Start Marketing Date : 2013-01-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1754
Start Marketing Date : 2013-06-20
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-0395
Start Marketing Date : 1994-05-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66653-003
Start Marketing Date : 2016-05-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
96
PharmaCompass offers a list of Amantadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amantadine Hydrochloride manufacturer or Amantadine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amantadine Hydrochloride manufacturer or Amantadine Hydrochloride supplier.
A Midantan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Midantan, including repackagers and relabelers. The FDA regulates Midantan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Midantan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Midantan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Midantan supplier is an individual or a company that provides Midantan active pharmaceutical ingredient (API) or Midantan finished formulations upon request. The Midantan suppliers may include Midantan API manufacturers, exporters, distributors and traders.
click here to find a list of Midantan suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Midantan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Midantan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Midantan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Midantan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Midantan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Midantan suppliers with NDC on PharmaCompass.
We have 8 companies offering Midantan
Get in contact with the supplier of your choice:
